Zila Inc - Current report filing (8-K)
April 15 2008 - 4:44PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) April 9, 2008
ZILA, INC.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
|
|
Delaware
|
|
0-17521
|
|
86-0619668
|
|
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File
Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
5227 North 7th Street, Phoenix, Arizona 85014-2800
(Address of Principal Executive Offices)
|
|
|
|
|
(602) 266-6700
(Registrant’s telephone number, including area code)
|
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (
see
General Instruction A.2. below):
|
|
|
|
|
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
TABLE OF CONTENTS
|
|
|
|
|
Item 5.02.
|
|
Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
April 9, 2008, Zila, Inc. (the “Company”) decided to
suspend the auto
allowance for the executive officers of the Company listed below. The
specific annual amounts which were
suspended are set forth below:
|
|
|
|
|
|
|
|
|
|
|
Suspended
|
|
|
|
|
|
Annual
|
|
|
|
|
|
Auto
|
|
|
|
|
|
Allowance
|
|
Name
|
|
Position
|
|
Amount
|
|
|
|
|
|
|
|
David A. Barshis
|
|
Senior Vice President and General
|
|
$8,400
|
|
|
|
Manager of Zila Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
|
|
Frank J. Bellizzi
|
|
Executive Vice President and
|
|
$9,600
|
|
|
|
President of Zila Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
|
|
Diane E. Klein
|
|
Vice President of Finance and
|
|
$8,400
|
|
|
|
Treasurer
|
|
|
|
|
|
|
|
|
|
Gary V. Klinefelter
|
|
Vice President, General Counsel and
|
|
$9,600
|
|
|
|
Secretary
|
|
|
|
|
|
|
|
|
The foregoing changes are effective May 12, 2008.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Dated: April 15, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ZILA, INC.
|
|
|
|
|
|
|
|
|
|
/s/
|
|
Gary V. Klinefelter
|
|
|
|
|
|
|
|
By:
|
|
Gary V. Klinefelter
|
|
|
|
|
|
Vice President and General Counsel
|
Zila (NASDAQ:ZILA)
Historical Stock Chart
From May 2024 to Jun 2024
Zila (NASDAQ:ZILA)
Historical Stock Chart
From Jun 2023 to Jun 2024
